MiMedx Group, Inc.(MDXG)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MDXG MiMedx Group, Inc.

盘后交易 02-09 17:05:22 EST

5.19

+0.04

+0.78%

盘后5.19

+0.000.00%

16:49 EST

最高5.21	最低5.07	成交量61.07万
今开5.12	昨收5.15	日振幅2.62%
总市值7.69亿	流通市值5.65亿	总股本1.48亿
成交额315.44万	换手率0.56%	流通股本1.09亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MDXG","market":"US","secType":"STK","nameCN":"MiMedx Group, Inc.","latestPrice":5.19,"timestamp":1770670800000,"preClose":5.15,"halted":0,"volume":610718,"hourTrading":{"tag":"盘后","latestPrice":5.19,"preClose":5.19,"latestTime":"16:49 EST","volume":16314,"amount":84670.16573400001,"timestamp":1770673772791,"change":0,"changeRate":0,"amplitude":0.000963},"delay":0,"changeRate":0.0077669902912621425,"floatShares":108772704,"shares":148102159,"eps":0.270077,"marketStatus":"盘后交易","change":0.04,"latestTime":"02-09 17:05:22 EST","open":5.12,"high":5.205,"low":5.07,"amount":3154398.16667,"amplitude":0.026214,"askPrice":5.65,"askSize":100,"bidPrice":5.19,"bidSize":3,"shortable":3,"etf":0,"ttmEps":0.270077,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770685200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1366862400000,"exchange":"NASDAQ","adjPreClose":5.15,"preHourTrading":{"tag":"盘前","latestPrice":5.12,"preClose":5.15,"latestTime":"09:29 EST","volume":1318,"amount":6825.330217999999,"timestamp":1770647399920,"change":-0.03,"changeRate":-0.005825,"amplitude":0.014777},"postHourTrading":{"tag":"盘后","latestPrice":5.19,"preClose":5.19,"latestTime":"16:49 EST","volume":16314,"amount":84670.16573400001,"timestamp":1770673772791,"change":0,"changeRate":0,"amplitude":0.000963},"volumeRatio":0.496596,"impliedVol":0.9258,"impliedVolPercentile":0.7171},"requestUrl":"/m/hq/s/MDXG/tweets","defaultTab":"tweets","newsList":[{"id":"1109681629","title":"MiMedx与Summit Products Group就多款创新外科与伤口护理产品达成独家分销协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1109681629","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109681629?lang=zh_cn&edition=full","pubTime":"2026-02-04 23:27","pubTimestamp":1770218850,"startTime":"0","endTime":"0","summary":"MiMedx Group, Inc.  已正式与Summit Products Group签署独家分销协议，将负责后者多款创新外科及伤口护理产品的市场推广与销售工作。此次合作旨在整合双方在医疗领域的专业优势，共同拓展产品市场覆盖范围。这些产品融合了创新技术，旨在提升临床治疗效果并优化患者护理体验。双方将依托各自在研发、生产与渠道方面的资源优势，共同推动创新医疗产品的商业化进程，为医疗机构和患者提供更全面的解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDXG","BK4139"],"gpt_icon":0},{"id":"1166046039","title":"MiMedx 2025财年Q3业绩会总结及问答精华：创纪录增长与战略展望","url":"https://stock-news.laohu8.com/highlight/detail?id=1166046039","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166046039?lang=zh_cn&edition=full","pubTime":"2025-10-31 01:41","pubTimestamp":1761846081,"startTime":"0","endTime":"0","summary":"MiMedx Group在2025财年第三季度实现了创纪录的财务业绩，净销售额达到1.14亿美元，同比增长35%。调整后毛利率为88%，较去年同期增长540个基点。第三季度伤口护理业务增长40%，外科手术业务增长26%。MiMedx Group在2025财年第三季度表现出色，创下了多项财务记录。管理层对未来充满信心，预计全年收入和调整后EBITDA利润率将进一步提升。尽管面临政策变化和市场竞争的挑战，MiMedx Group凭借其强大的财务状况和战略准备，有望在未来继续保持增长势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDXG"],"gpt_icon":0},{"id":"1153767431","title":"异动解读 | MiMedx集团盘后大涨7.79%，2025年销售增长预期乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1153767431","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153767431?lang=zh_cn&edition=full","pubTime":"2025-10-30 04:58","pubTimestamp":1761771518,"startTime":"0","endTime":"0","summary":"周三盘后交易中，MiMedx Group, Inc.股价大幅上涨7.79%，引发市场关注。这一显著涨幅似乎源于公司最新发布的积极财务展望和战略规划。根据公司最新公告，MiMedx预计2025年净销售额增长将达到中高个位数百分比，相较于2024年的业绩。此外，MiMedx还透露，公司正在等待美国医疗保险和医疗补助服务中心最终确定2026年的报销规则。在此期间，公司正积极规划多种潜在情景，以应对不同的政策结果。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MDXG"],"gpt_icon":0},{"id":"1151181949","title":"MiMedx Group：在等待CMS最终确定2026年报销规则之际，规划多种潜在情景","url":"https://stock-news.laohu8.com/highlight/detail?id=1151181949","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151181949?lang=zh_cn&edition=full","pubTime":"2025-10-30 04:18","pubTimestamp":1761769103,"startTime":"0","endTime":"0","summary":"MiMedx Group：在等待CMS最终确定2026年报销规则之际，规划多种潜在情景","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDXG","BK4139"],"gpt_icon":0},{"id":"1181993836","title":"MiMedx Group, Inc.：预计2025年净销售增长将达到相对于2024年的中高个位数百分比","url":"https://stock-news.laohu8.com/highlight/detail?id=1181993836","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181993836?lang=zh_cn&edition=full","pubTime":"2025-10-30 04:05","pubTimestamp":1761768309,"startTime":"0","endTime":"0","summary":"MiMedx Group, Inc.：预计2025年净销售增长将达到相对于2024年的中高个位数百分比","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDXG"],"gpt_icon":0},{"id":"2516454806","title":"Mimedx Group, Inc2024财年实现净利润42.00百万美元，同比减少37.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516454806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516454806?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:01","pubTimestamp":1740931266,"startTime":"0","endTime":"0","summary":"3月3日，Mimedx Group, Inc公布财报，公告显示公司2024财年净利润为42.00百万美元，同比减少37.72%；其中营业收入为3.49亿美元，同比增加8.72%，每股基本收益为0.29美元。从资产负债表来看，Mimedx Group, Inc总负债70.81百万美元，其中短期债务2.31百万美元，资产负债比为0.04，流动比率为0.05。机构评级：截至2025年3月3日，当前有5家机构对Mimedx Group, Inc目标价做出预测，其中目标均价为13.40美元，其中最低目标价为12.00美元，最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000136abe4acc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000136abe4acc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDXG"],"gpt_icon":0},{"id":"2514380338","title":"坎托菲茨杰拉德公司：重申MiMedx Group(MDXG.US)评级，由增持调整至增持评级, 目标价由13.00美元调整至13.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514380338","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514380338?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:41","pubTimestamp":1740674501,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申MiMedx Group(MDXG.US)评级，由增持调整至增持评级, 目标价由13.00美元调整至13.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28004148440840.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MDXG"],"gpt_icon":0},{"id":"1176129083","title":"MiMedx Group第四季度每股收益$0.07，与预期一致，销售额$92.91百万，超预期$89.42百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1176129083","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176129083?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:12","pubTimestamp":1740604357,"startTime":"0","endTime":"0","summary":"MiMedx Group  公布季度每股收益$0.07，符合分析师共识预期。公司公布季度销售额$92.91百万，超出分析师共识预期的$89.42百万，超出3.90%。与去年同期销售额$86.83百万相比，增长了7.00%。以上内容来自Benzinga Earnings专栏，原文如下：MiMedx Group  reported quarterly earnings of $0.07 per share which met the analyst consensus estimate. This is a 75 percent increase over earnings of $0.04 per share from the same period last year.  The company reported quarterly sales of $92.91 million which beat the analyst consensus estimate of $89.42 million by 3.90 percent.  This is a 7.00 percent inc","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"MiMedx Group第四季度每股收益$0.07，与预期一致，销售额$92.91百万，超预期$89.42百万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDXG"],"gpt_icon":0},{"id":"2506510607","title":"Mimedx Group, Inc盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506510607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506510607?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:35","pubTimestamp":1738078518,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时35分，Mimedx Group, Inc股票出现波动，股价快速上涨5.11%。Mimedx Group, Inc股票所在的生物技术行业中，整体涨幅为0.04%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128233518987572f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128233518987572f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MDXG"],"gpt_icon":0},{"id":"2506930339","title":"Mimedx Group, Inc盘中异动 大幅下跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506930339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506930339?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:32","pubTimestamp":1737988378,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时32分，Mimedx Group, Inc股票出现异动，股价大幅下跌5.35%。Mimedx Group, Inc股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Akero Therapeutics, Inc.、89Bio, Inc.、Onconetix, Inc.涨幅较大，Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为720.86%、41.82%、37.51%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Evaxion Biotech As、Tevogen Bio Holdings Inc.，振幅分别为37.50%、14.59%、14.07%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272232589874af6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272232589874af6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MDXG"],"gpt_icon":0},{"id":"2490487660","title":"Mimedx Group, Inc盘中异动 早盘股价大涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490487660","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490487660?lang=zh_cn&edition=full","pubTime":"2024-12-11 00:21","pubTimestamp":1733847678,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日00时21分，Mimedx Group, Inc股票出现波动，股价快速拉升5.33%。Mimedx Group, Inc股票所在的生物技术行业中，整体跌幅为1.19%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211002118984b11b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211002118984b11b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MDXG"],"gpt_icon":0},{"id":"2484311084","title":"Mimedx Group, Inc盘中异动 早盘股价大跌5.95%报8.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484311084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484311084?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:33","pubTimestamp":1732113209,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时33分，Mimedx Group, Inc股票出现异动，股价快速跳水5.95%。截至发稿，该股报8.69美元/股，成交量7.9288万股，换手率0.05%，振幅5.06%。Mimedx Group, Inc股票所在的生物技术行业中，整体涨幅为0.34%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223329abd23317&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223329abd23317&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MDXG"],"gpt_icon":0},{"id":"2483139804","title":"Mimedx Group, Inc盘中异动 股价大涨7.50%报8.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483139804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483139804?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:32","pubTimestamp":1731594754,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时32分，Mimedx Group, Inc股票出现波动，股价快速上涨7.50%。截至发稿，该股报8.03美元/股，成交量23.0549万股，换手率0.16%，振幅2.41%。Mimedx Group, Inc股票所在的生物技术行业中，整体跌幅为0.47%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422323495be2ca6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422323495be2ca6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDXG","BK4183","ELAB","BK4139"],"gpt_icon":0},{"id":"2480983293","title":"Mimedx Group, Inc2024财年第三财季实现净利润7.88百万美元，同比减少7.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480983293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480983293?lang=zh_cn&edition=full","pubTime":"2024-11-04 00:00","pubTimestamp":1730649656,"startTime":"0","endTime":"0","summary":"11月4日，Mimedx Group, Inc公布财报，公告显示公司2024财年第三财季净利润为7.88百万美元，同比减少7.62%；其中营业收入为84.06百万美元，同比增加2.88%，每股基本收益为0.06美元。从资产负债表来看，Mimedx Group, Inc总负债62.88百万美元，其中短期债务1000000.00美元，资产负债比为0.04，流动比率为0.05。机构评级：截至2024年11月4日，当前有5家机构对Mimedx Group, Inc目标价做出预测，其中目标均价为12.20美元，其中最低目标价为11.00美元，最高目标价为14.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000148ab9b4f01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104000148ab9b4f01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDXG"],"gpt_icon":0},{"id":"2479835038","title":"Mimedx Group, Inc盘中异动 早盘急速上涨17.40%报6.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479835038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479835038?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:34","pubTimestamp":1730381643,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时34分，Mimedx Group, Inc股票出现波动，股价快速拉升17.40%。截至发稿，该股报6.68美元/股，成交量8.5479万股，换手率0.06%，振幅8.96%。Mimedx Group, Inc股票所在的生物技术行业中，整体跌幅为1.87%。Mimedx Group, Inc公司简介：MiMedx Group Inc开发和销售再生生物材料产品和生物植入物，这些产品和植入物由人类羊膜、出生组织和人类皮肤和骨骼制成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121340395bd9c5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103121340395bd9c5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDXG","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mimedx.com","stockEarnings":[{"period":"1week","weight":0.0078},{"period":"1month","weight":-0.2003},{"period":"3month","weight":-0.3078},{"period":"6month","weight":-0.2664},{"period":"1year","weight":-0.3941},{"period":"ytd","weight":-0.2393}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MiMedx Group, Inc.在佛罗里达州注册成立。该公司是专注于帮助人类愈合的胎盘生物制剂的先驱和领导者。凭借十多年来帮助临床医生管理慢性和难以愈合的伤口，MIMEDX致力于为应用于医疗保健的伤口护理、烧伤和手术领域提供领先的产品组合。该公司的愿景是通过不懈的创新，成为全球领先的康复解决方案提供商，以恢复生活质量。凭借深厚的专业知识、领先的同行评审数据以及胎盘生物制剂领域广泛的额外科学和真实世界证据库，MIMEDX开发和分销胎盘组织同种异体移植物，这些移植物使用受专利保护的专有工艺制造，适用于医疗保健的多个部门。","yearOnYearQuotes":[{"month":1,"riseRate":0.307692,"avgChangeRate":0.001131},{"month":2,"riseRate":0.615385,"avgChangeRate":-0.002576},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.061808},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.030057},{"month":5,"riseRate":0.692308,"avgChangeRate":0.128744},{"month":6,"riseRate":0.538462,"avgChangeRate":0.066117},{"month":7,"riseRate":0.384615,"avgChangeRate":0.011587},{"month":8,"riseRate":0.461538,"avgChangeRate":0.036935},{"month":9,"riseRate":0.230769,"avgChangeRate":-0.09977},{"month":10,"riseRate":0.692308,"avgChangeRate":0.062432},{"month":11,"riseRate":0.769231,"avgChangeRate":0.084769},{"month":12,"riseRate":0.615385,"avgChangeRate":0.027495}],"exchange":"NASDAQ","name":"MiMedx Group, Inc.","nameEN":"MiMedx Group, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MiMedx Group, Inc.(MDXG)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MiMedx Group, Inc.(MDXG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MiMedx Group, Inc.,MDXG,MiMedx Group, Inc.股票,MiMedx Group, Inc.股票老虎,MiMedx Group, Inc.股票老虎国际,MiMedx Group, Inc.行情,MiMedx Group, Inc.股票行情,MiMedx Group, Inc.股价,MiMedx Group, Inc.股市,MiMedx Group, Inc.股票价格,MiMedx Group, Inc.股票交易,MiMedx Group, Inc.股票购买,MiMedx Group, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MiMedx Group, Inc.(MDXG)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MiMedx Group, Inc.(MDXG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}